No indication of highly pathogenic avian influenza infections in Dutch cows., PMID:40458141
Kinetic MUNANA assay reveals functionally relevant antibody epitopes on Influenza A virus neuraminidase., PMID:40348878
Synthetic Neuraminidase Vaccine Induces Cross-Species and Multi-Subtype Protection., PMID:40333263
Seroprevalence of anti-influenza antibodies in humans and characterization of seasonal influenza viruses isolated in Russia during the 2023-2024 flu season., PMID:40307541
Chimeric virus-like particles of nodavirus displaying M2e of human and avian influenza A viruses as a potential dual-use vaccine: Inducing a broader immune response and protecting mice against viral infections., PMID:40286563
Multivalent H3 COBRA-based influenza vaccine elicits enhanced immune response in a pre-immune elderly ferret model., PMID:40267617
Dual roles of influenza B virus neuraminidase mRNA vaccine in enhancing cross-lineage protection by supplementing inactivated split vaccination., PMID:40265888
Design, Synthesis and In Vivo Evaluation of a Candidate Fusion Epitopic Construct Vaccine Based on M2e, HA1, HA2, NA and NP Fragments of the Highly Pathogenic Avian H5N1 Influenza Virus., PMID:40256578
A monoclonal anti-hemagglutinin stem antibody modified with zanamivir protects against both influenza A and B viruses., PMID:40193611
Immunogenicity and protective efficacy of an inactivated bivalent vaccine containing two recombinant H1N1 and H3N2 swine influenza virus strains., PMID:40192841
Live-attenuated pandemic H1N1 influenza vaccines expressing computationally optimized broadly reactive antigens (COBRAs) are immunogenic and protective in mice and ferrets., PMID:40186991
Identification of a seasonal influenza vaccine-induced broadly protective neuraminidase antibody., PMID:40178595
Broad Mucosal and Systemic Immunity in Mice Induced by Intranasal Booster With a Novel Recombinant Adenoviral Based Vaccine Protects Against Divergent Influenza A Virus., PMID:40145257
A strategy of enhancing the protective efficacy of seasonal influenza vaccines by providing additional immunity to neuraminidase and M2e., PMID:40139072
Emergence of a novel reassortant H3N3 avian influenza virus with enhanced pathogenicity and transmissibility in chickens in China., PMID:40069883
A single dose of inactivated influenza virus vaccine expressing COBRA hemagglutinin elicits broadly-reactive and long-lasting protection., PMID:39982912
Evaluation of an N1 NA antibody-specific enzyme-linked lectin assay for detection of H5N1 highly pathogenic avian influenza virus infection in vaccinated birds., PMID:39956396
Replication-incompetent VSV-based vaccine elicits protective responses against SARS-CoV-2 and influenza virus., PMID:39879304
A Study on the Induction of Multi-Type Immune Responses in Mice via an mRNA Vaccine Based on Hemagglutinin and Neuraminidase Antigen., PMID:39852870
Surveillance of Highly Pathogenic Avian Influenza Virus in Wild Canids from Pennsylvania, USA., PMID:39765604
Anti-neuraminidase and anti-hemagglutinin stalk responses to different influenza a(H7N9) vaccine regimens., PMID:39756216
Comparison of neuraminidase inhibiting antibody responses elicited by egg- and cell-derived influenza vaccines., PMID:39754936
Identification of a broad-inhibition influenza neuraminidase antibody from pre-existing memory B cells., PMID:39740671
Targets of influenza human T-cell response are mostly conserved in H5N1., PMID:39714185
Immunization and challenge trials in a murine model using different inactivated recombinant vaccines against H1N1 swine influenza virus circulating in Brazil., PMID:39709805
Cross-neutralization of Influenza A by SARS-CoV-2 specific neutralizing antibodies and polyclonal plasma: Is pre-exposure to SARS-CoV-2 protective against Influenza A?, PMID:39654774
A neuraminidase-based inactivated influenza virus vaccine significantly reduced virus replication and pathology following homologous challenge in swine., PMID:39645432
Differential antigenic imprinting effects between influenza H1N1 hemagglutinin and neuraminidase in a mouse model., PMID:39636110
Evolutionary analysis of Hemagglutinin and neuraminidase gene variation in H1N1 swine influenza virus from vaccine intervention in China., PMID:39567587
Vaccine efficacy induced by 2020-2021 seasonal influenza-derived H3N1 virus-like particles co-expressing M2e5x or N2., PMID:39551038
Measures of Population Immunity Can Predict the Dominant Clade of Influenza A (H3N2) in the 2017-2018 Season and Reveal Age-Associated Differences in Susceptibility and Antibody-Binding Specificity., PMID:39501522
A human monoclonal antibody targeting the monomeric N6 neuraminidase confers protection against avian H5N6 influenza virus infection., PMID:39402031
Jamaican fruit bats mount a stable and highly neutralizing antibody response after bat influenza virus infection., PMID:39382992
Improved influenza vaccine responses after expression of multiple viral glycoproteins from a single mRNA., PMID:39379405
Molecular epidemiology and vaccine compatibility analysis of seasonal influenza A viruses in the context of COVID-19 epidemic in Wuhan, China., PMID:39370830
Broadly cross-reactive immune responses in chickens immunized with chimeric virus-like particles of nodavirus displaying the M2e originated from avian and human influenza A viruses., PMID:39341478
Antigenic drift and subtype interference shape A(H3N2) epidemic dynamics in the United States., PMID:39319780
COBRA N2 NA vaccines induce protective immune responses against influenza viral infection., PMID:39291424
Vaccine-induced NA immunity decreases viral shedding, but does not disrupt chains of airborne transmission for the 2009 pandemic H1N1 virus in ferrets., PMID:39248566
Prospects for a sequence-based taxonomy of influenza A virus subtypes., PMID:39247559
Enhancing NA immunogenicity through novel VLP designs., PMID:39197219
A(H2N2) and A(H3N2) influenza pandemics elicited durable cross-reactive and protective antibodies against avian N2 neuraminidases., PMID:38961067
Natural variation in neuraminidase activity influences the evolutionary potential of the seasonal H1N1 lineage hemagglutinin., PMID:38915760
Broadly protective bispecific antibodies that simultaneously target influenza virus hemagglutinin and neuraminidase., PMID:38899870
COBRA HA and NA vaccination elicits long-live protective immune responses against pre-pandemic H2, H5, and H7 influenza virus subtypes., PMID:38850895
Nanoparticle display of neuraminidase elicits enhanced antibody responses and protection against influenza A virus challenge., PMID:38821988
H1N1 nanobody development and therapeutic efficacy verification in H1N1-challenged mice., PMID:38805966
The antigenic landscape of human influenza N2 neuraminidases from 2009 until 2017., PMID:38805550
Epitopes in the HA and NA of H5 and H7 avian influenza viruses that are important for antigenic drift., PMID:38734891
Genomic characterization of Influenza A (H1N1)pdm09 and SARS-CoV-2 from Influenza Like Illness (ILI) and Severe Acute Respiratory Illness (SARI) cases reported between July-December, 2022., PMID:38724525
For research use only. Not for human or drug use.
